Symposium part IV: Investigative approaches to endocervical pathology

International Journal of Gynecological Pathology

Volumn 21, Issue 4, 2002, Pages 360-367

  Wells, Michael ^a,c   Brown, Laurence J R ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cell proliferation; Endocervix; Human papillomaviruses; Mucins; Oncogene; Pathology; Tumor suppressor gene

Indexed keywords

BLOOD GROUP ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; GLYCOPROTEIN; LECTIN; MUCIN; PROTEIN P53; TELOMERASE;

CANCER DIAGNOSIS; CANCER INCIDENCE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME MICRODISSECTION; COMPARATIVE GENOMIC HYBRIDIZATION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE K RAS; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0036783688     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200210000-00005     Document Type: Conference Paper

References (60)

1. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: A 24-year population-based study
2. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening
3. Parkin DM International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas
4. The continuing increase in adenocarcinoma of the uterine cervix: A birth cohort phenomenon
5. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England
6. Observations of high iron diamine-Alcian blue stain in uterine cervical glandular lesions
7. Stratified mucin-producing intraepithelial lesions of the cervix. Adenosquamous or columnar neoplasia?
8. Minimal deviation adenocarcinoma of the uterine cervix has abnormal expression of sex steroid receptors, CA125, and gastric mucin
9. Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix
10. Utility of the monoclonal antibody HIK 1083 in the diagnosis of adenoma malignum of the uterine cervix
11. Florid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia: Worrisome benign mimic of "adenoma malignum"
12. Mucins of the human endocervix
13. Differential expression of MUC2 and MUC5AC in benign and malignant glandular lesions of the cervix
14. Cervical adenocarcinomas express markers common to gastric, intestinal and pancreatobiliary epithelial cells
15. Characterization of complex carbohydrates in cervical glandular intraepithelial neoplasia and invasive adenocarcinoma
16. Semi-quantitative immunohistochemical studies of blood group antigen A, B, H, Lea, Leb structures and Ii backbone chains in the normal human cervix and in cervical adenocarcinoma
17. Endocervical tubal metaplasia and adenocarcinoma in situ: Role of immunohistochemistry for carcinoembryonic antigen and vimentin in differential diagnosis
18. Distinction between endometrial and endocervical adenocarcinoma: An immunohistochemical study
19. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas
20. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia
21. CD44 is a marker of endocervical neoplasia
22. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression
23. Molecular characterization of adenocarcinoma of the cervix
24. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix
25. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix
26. Different pattern of loss of heterozygosity among endocervical-type adenocarcinoma, endometrioid-type adenocarcinoma and adenoma malignum of the uterine cervix
27. A distinct region of chromosome 19p 13.3 associated with the sporadic form of adenoma malignum of the uterine cervix
28. 1997 Telomerase activity in cervical cancer
29. Telomerase activity and expression of its RNA component in cervical lesions
30. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer
31. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix
32. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation
33. The significance of Erb-b2 immunostaining in cervical cancer
34. Expressions of c-erbB-2, epidermal growth factor receptor and panras proto-oncogenes in adenocarcinoma of the cervix: Correlation with clinical prognosis
35. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix
36. Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrioid metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material
37. Quantitative analysis of MIB-1 reactivity in inflammatory, hyperplastic and neoplastic endocervical lesions
38. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen and p53 in the differential diagnosis of glandular lesions of the cervix
39. Endocervical intraepithelial glandular atypia (dysplasia): A histopathologic, human papillomavirus, and MIB-1 analysis of 25 cases
40. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix
41. The HPV status of 114 endocervical adenocarcinoma cases by dot blot hybridization
42. Adenocarcinoma in situ of the endocervix: Human papillomavirus determination by dot blot hybridization and polymerase chain reaction amplification
43. The human papillomavirus status of invasive cervical adenocarcinoma: A clinicopathological and outcome analysis
44. Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16
45. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction
46. Type of human papillomavirus is related to clinical features of cervical carcinoma
47. Adenocarcinoma of the cervix and adenocarcinoma of the endometrium: Distinction with PCR-mediated detection of HPV DNA
48. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction
49. Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade
50. Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix
51. Risk factors for rapid onset cervical cancer
52. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma
53. Detection of high-risk human papillomavirus in adenoid cystic carcinoma of the uterine cervix
54. Adenoid basal carcinoma of the uterine cervix: Detection of integrated human papillomavirus in a rare tumor of putative "reserve cell origin."
55. The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix
56. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: Oncogene/tumor suppressor gene alterations and human papillomavirus genotyping
57. Human papillomavirus detection and p53 expression in clear cell adenocarcinoma of the vagina and cervix
58. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical carcinoma
59. Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix
60. Analysis and clinical implications of p53 gene mutations and human papillomavirus types 16 and 18 infection in primary adenocarcinoma of the uterine cervix